IP Verse

Trophoblast Glycoprotein (5t4, Tpbg) Specific Chimeric Antigen Receptors For Cancer Immunotherapy - EP3189073

PATENT ANALYSIS

Patent Details

Grant Date
Dec 25, 2019
Company
CELLECTIS
Oppositions

OXFORD BIOMEDICA (UK) LIMITED

More patents of Cellectis

EP2997141

EP3116902

EP3189073

Want to monitor this patent?

Feel free to send us a message here and we will get back to you